Invesco Ltd. Fibrogen Inc Transaction History

Invesco Ltd.

$499 Billion
Q3 2024

A detailed history of Invesco Ltd. transactions in Fibrogen Inc stock. As of the latest transaction made, Invesco Ltd. holds 120,917 shares of FGEN stock, worth $47,157. This represents 0.0% of its overall portfolio holdings.

Number of Shares

120,917

Previous 34,434 251.16%

Holding current value

$47,157

Previous $30,000 60.0%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$0.33 - $1.26 $28,539 - $108,968	86,483 Added 251.16%	120,917 $48,000
Q2 2024 Aug 13, 2024	SELL	$0.89 - $2.36 $4,779 - $12,673	-5,370 Reduced 13.49%	34,434 $30,000
Q1 2024 May 14, 2024	SELL	$0.73 - $2.73 $11,387 - $42,585	-15,599 Reduced 28.16%	39,804 $93,000
Q4 2023 Feb 12, 2024	SELL	$0.38 - $0.91 $15,823 - $37,892	-41,640 Reduced 42.91%	55,403 $49,000
Q3 2023 Nov 13, 2023	BUY	$0.79 - $2.83 $34,847 - $124,834	44,111 Added 83.34%	97,043 $83,000
Q2 2023 Aug 11, 2023	SELL	$2.49 - $20.59 $1.05 Million - $8.67 Million	-421,075 Reduced 88.83%	52,932 $142,000
Q1 2023 May 12, 2023	BUY	$15.95 - $25.18 $6.28 Million - $9.91 Million	393,733 Added 490.49%	474,007 $8.84 Million
Q4 2022 Feb 13, 2023	SELL	$13.27 - $17.73 $6.52 Million - $8.71 Million	-491,340 Reduced 85.96%	80,274 $1.29 Million
Q3 2022 Nov 14, 2022	BUY	$11.4 - $14.6 $5.6 Million - $7.17 Million	491,436 Added 612.93%	571,614 $7.44 Million
Q2 2022 Aug 15, 2022	SELL	$7.94 - $12.96 $3.35 Million - $5.47 Million	-422,344 Reduced 84.04%	80,178 $847,000
Q1 2022 May 16, 2022	BUY	$12.02 - $16.79 $5.26 Million - $7.34 Million	437,439 Added 672.12%	502,522 $6.04 Million
Q4 2021 Feb 14, 2022	BUY	$9.93 - $15.39 $106,578 - $165,180	10,733 Added 19.75%	65,083 $918,000
Q3 2021 Nov 15, 2021	SELL	$10.18 - $26.64 $3.62 Million - $9.47 Million	-355,646 Reduced 86.74%	54,350 $555,000
Q2 2021 Aug 17, 2021	BUY	$18.57 - $35.68 $4.09 Million - $7.86 Million	220,297 Added 116.13%	409,996 $10.9 Million
Q1 2021 May 17, 2021	BUY	$31.0 - $55.72 $226,858 - $407,758	7,318 Added 4.01%	189,699 $6.58 Million
Q4 2020 Feb 16, 2021	BUY	$37.09 - $48.97 $714,167 - $942,917	19,255 Added 11.8%	182,381 $6.77 Million
Q3 2020 Nov 16, 2020	BUY	$40.47 - $45.5 $5.89 Million - $6.62 Million	145,499 Added 825.43%	163,126 $6.71 Million
Q2 2020 Aug 14, 2020	SELL	$32.57 - $42.83 $4.65 Million - $6.12 Million	-142,911 Reduced 89.02%	17,627 $715,000
Q1 2020 May 15, 2020	BUY	$23.3 - $45.96 $3.44 Million - $6.78 Million	147,573 Added 1138.24%	160,538 $5.58 Million
Q4 2019 Feb 14, 2020	SELL	$34.58 - $48.06 $4.59 Million - $6.38 Million	-132,775 Reduced 91.1%	12,965 $556,000
Q3 2019 Nov 14, 2019	SELL	$36.98 - $48.45 $11.3 Million - $14.8 Million	-305,805 Reduced 67.72%	145,740 $5.39 Million
Q2 2019 Aug 14, 2019	BUY	$35.13 - $55.53 $10.8 Million - $17 Million	306,510 Added 211.34%	451,545 $20.4 Million
Q1 2019 May 15, 2019	SELL	$42.83 - $59.91 $1.55 Million - $2.17 Million	-36,155 Reduced 19.95%	145,035 $7.88 Million
Q4 2018 Feb 14, 2019	BUY	$37.97 - $60.16 $6.88 Million - $10.9 Million	181,190 New	181,190 $8.39 Million

Others Institutions Holding FGEN

# of Institutions

Shares Held

47.1M

Call Options Held

387K

Put Options Held

672K

View Full List

About FIBROGEN INC

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $36.6M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

More about FGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account